Dendreon’s Prostate Cancer Drug Will not Go Before an Outside Panel

US FDA sees no public hearing for Dendreon (DNDN) vaccine – No plans for advisory panel said FDA spokeswoman Shelly Burgess. – Reuters

Be the first to comment

Leave a Reply

Your email address will not be published.


*